
HHS Encouraging Americans to Review Their Medicare Options During Open Enrollment

WASHINGTON — Medicare Open Enrollment begins on Saturday, Oct. 15, and officials with the Department of Health and Human Services are encouraging Medicare recipients to review and compare their options due to beneficial changes stemming from the passage of the Inflation Reduction Act.
“We are committed to providing comprehensive and easily accessible information to support people with Medicare in their decision making,” said Chiquita Brooks-LaSure, administrator of the Centers for Medicare & Medicaid Services, in a written statement.
“Medicare.gov makes it easier than ever to compare coverage options and shop for plans. People can do a side-by-side comparison of plan coverage, costs, and quality ratings to help them more easily see the differences between plans,” she said.
Medicare’s Open Enrollment period, which extends through Dec. 7 this year, gives people with Medicare the opportunity to make changes to their health plan or prescription drug plan, pick a Medicare Advantage plan, or return to original Medicare (also referred to as Medicare Part A and Part B).
Coverage changes take effect Jan. 1, 2023.
In a press release the department noted that Medicare plans can change their offerings and costs every year, and individuals’ health needs can change from year-to-year, too.
“Now is the time for people with Medicare to review their coverage options and make a choice that best meets their health care needs,” it said.
Most if not all people with Medicare will see lower average premiums for Medicare Part B, Medicare Advantage and Medicare Part D prescription drug plans in 2023.
This year, as a result of President Joe Biden signing the Inflation Reduction Act into law Medicare enrollees will also see lower costs for insulin and vaccines beginning in 2023.
Starting in 2023, all people with Medicare who take insulin covered by their prescription drug plan or through a traditional pump covered under original Medicare will pay no more than $35 in cost-sharing for a month’s supply of each covered insulin product.
People with Medicare also will not pay a deductible with respect to each covered insulin product.
Additionally, people with Medicare drug coverage will pay nothing out-of-pocket for adult vaccines recommended by the Advisory Committee on Immunization Practices — including the shingles vaccine and Tetanus-Diphtheria-Whooping Cough vaccine.
More information on Medicare and the changes associated with the Inflation Reduction Act can be found here.
Dan can be reached at [email protected] and at https://twitter.com/DanMcCue.
In The News
Health
Voting
Health
RALEIGH, N.C. (AP) — A Medicaid expansion deal in North Carolina received final legislative approval on Thursday, ending a decade of debate... Read More
RALEIGH, N.C. (AP) — A Medicaid expansion deal in North Carolina received final legislative approval on Thursday, ending a decade of debate over whether the closely politically divided state should accept the federal government's coverage for hundreds of thousands of low-income adults. North Carolina is one of several... Read More
WASHINGTON — The chief executive of Moderna Inc. defended his plan to quadruple the price of the COVID-19 vaccine during... Read More
WASHINGTON — The chief executive of Moderna Inc. defended his plan to quadruple the price of the COVID-19 vaccine during a Senate hearing Wednesday by saying his company is preparing for a sharp decline in demand. With as much as a 90% drop in customers as... Read More
NEW YORK (AP) — Nearly 200 years after Ludwig van Beethoven's death, researchers pulled DNA from strands of his hair,... Read More
NEW YORK (AP) — Nearly 200 years after Ludwig van Beethoven's death, researchers pulled DNA from strands of his hair, searching for clues about the health problems and hearing loss that plagued him. They weren't able to crack the case of the German composer's deafness or... Read More
NEW YORK (AP) — U.S. cases of a dangerous fungus tripled over just three years, and more than half of... Read More
NEW YORK (AP) — U.S. cases of a dangerous fungus tripled over just three years, and more than half of states have now reported it, according to a new study. The COVID-19 pandemic likely drove part of the increase, researchers at the Centers for Disease Control... Read More
WASHINGTON — A week after the House overwhelmingly voted to declassify any and all information related to the origin of... Read More
WASHINGTON — A week after the House overwhelmingly voted to declassify any and all information related to the origin of COVID-19, President Joe Biden signed the measure into law, saying, “I share the Congress’ goal of releasing as much information as possible” about the virus. The... Read More
BOSTON — Encouraged by positive topline results from its phase 3 trial for its new therapy for adults with schizophrenia,... Read More
BOSTON — Encouraged by positive topline results from its phase 3 trial for its new therapy for adults with schizophrenia, Karuna Therapeutics announced Monday that it is on track to submit KarXT to the Food and Drug Administration for approval by summer. If that comes to... Read More